beta
ECYT
Endocyte Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Endocyte Inc is a biopharmaceutical company. It is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases.
Market Cap: 169 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.endocyte.com
Shares Outstanding: 47.9 Million
Float: 45.8 Million
Dividend: 0.0 (0.0%)
Beta: 1.893802
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1264 trading days
From: 2014-03-21 To: 2018-12-20
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|